Renal replacement therapy and conservative management: NICE guideline [NG107] – NICE

This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5. It aims to improve quality of life by making recommendations on planning, starting and switching treatments, and coordinating

NephroCheck test to help assess the risk of acute kidney injury in critically ill patients: Medtech innovation briefing [MIB156] – NICE

The technology described in this briefing is the NephroCheck (including VITROS NephroCheck) test. It is an in vitro diagnostic test used to measure urinary biomarkers of kidney injury as an aid in detecting acute kidney injury. The innovative aspects are that NephroCheck is claimed